Effects of Bacterial-Derived Protein and Whey Protein on Blood Sugar, Insulin, and Amino Acid Levels
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07943676. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Impact of Bacteria-derived Protein vs. Whey on Amino Acid Appearance and Glycemic and Insulinemic Response
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the short-term effects of a protein produced through bacterial fermentation with whey protein, a milk-based protein, on blood sugar, insulin, and amino acid levels in healthy, physically active men aged 18-60 years. The main question is whether these two protein sources produce different changes in blood sugar, insulin, and amino acid levels when consumed alone or with carbohydrate. The study will also compare the responses to protein plus carbohydrate with the response to carbohydrate alone. Participants will consume each test drink on separate testing days after an overnight fast. Blood samples will be collected before and for three hours after each drink to measure changes over time. This study will help researchers better understand how the body responds to bacterial-derived protein compared with whey protein.
Study identification
- NCT ID
- NCT07943676
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 15 participants
Conditions and interventions
Interventions
- Bacterial-Derived Protein Dietary Supplement
- Whey Protein Dietary Supplement
- Oral Dextrose Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2022 (Actual)
- Primary completion
- Aug 30, 2023 (Actual)
- Completion
- Nov 30, 2023 (Actual)
- Last update posted
- Nov 17, 2026
2022 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Texas Woman's University | Denton | Texas | 76209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07943676, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2026 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.